Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Negative feedback via RSK modulates Erk-dependent progression from naïve pluripotency.

Nett IR, Mulas C, Gatto L, Lilley KS, Smith A.

EMBO Rep. 2018 Jun 12. pii: e45642. doi: 10.15252/embr.201745642. [Epub ahead of print]

2.

Defining murine organogenesis at single-cell resolution reveals a role for the leukotriene pathway in regulating blood progenitor formation.

Ibarra-Soria X, Jawaid W, Pijuan-Sala B, Ladopoulos V, Scialdone A, Jörg DJ, Tyser RCV, Calero-Nieto FJ, Mulas C, Nichols J, Vallier L, Srinivas S, Simons BD, Göttgens B, Marioni JC.

Nat Cell Biol. 2018 Feb;20(2):127-134. doi: 10.1038/s41556-017-0013-z. Epub 2018 Jan 8.

PMID:
29311656
3.

Single-Cell Landscape of Transcriptional Heterogeneity and Cell Fate Decisions during Mouse Early Gastrulation.

Mohammed H, Hernando-Herraez I, Savino A, Scialdone A, Macaulay I, Mulas C, Chandra T, Voet T, Dean W, Nichols J, Marioni JC, Reik W.

Cell Rep. 2017 Aug 1;20(5):1215-1228. doi: 10.1016/j.celrep.2017.07.009.

4.

NODAL Secures Pluripotency upon Embryonic Stem Cell Progression from the Ground State.

Mulas C, Kalkan T, Smith A.

Stem Cell Reports. 2017 Jul 11;9(1):77-91. doi: 10.1016/j.stemcr.2017.05.033. Epub 2017 Jun 29.

5.

Tracking the embryonic stem cell transition from ground state pluripotency.

Kalkan T, Olova N, Roode M, Mulas C, Lee HJ, Nett I, Marks H, Walker R, Stunnenberg HG, Lilley KS, Nichols J, Reik W, Bertone P, Smith A.

Development. 2017 Apr 1;144(7):1221-1234. doi: 10.1242/dev.142711. Epub 2017 Feb 7.

6.

Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.

Solla P, Fasano A, Cannas A, Mulas CS, Marrosu MG, Lang AE, Marrosu F.

Parkinsonism Relat Disord. 2015 Aug;21(8):968-71. doi: 10.1016/j.parkreldis.2015.05.018. Epub 2015 Jun 10.

PMID:
26071817
7.

Paraphilias and paraphilic disorders in Parkinson's disease: A systematic review of the literature.

Solla P, Bortolato M, Cannas A, Mulas CS, Marrosu F.

Mov Disord. 2015 Apr 15;30(5):604-13. doi: 10.1002/mds.26157. Epub 2015 Mar 11. Review.

8.

The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study.

Macciò A, Madeddu C, Gramignano G, Mulas C, Tanca L, Cherchi MC, Floris C, Omoto I, Barracca A, Ganz T.

Haematologica. 2015 Jan;100(1):124-32. doi: 10.3324/haematol.2014.112813. Epub 2014 Sep 19.

9.

Delusional jealousy in Parkinson's disease patients with and without dementia.

Solla P, Cannas A, Mulas CS, Marrosu F.

Neurol Sci. 2014 Aug;35(8):1307-8. doi: 10.1007/s10072-014-1720-x. Epub 2014 Mar 25. No abstract available.

PMID:
24664231
10.

A prospective study on inflammatory parameters in obese patients after sleeve gastrectomy.

Gumbau V, Bruna M, Canelles E, Guaita M, Mulas C, Basés C, Celma I, Puche J, Marcaida G, Oviedo M, Vázquez A.

Obes Surg. 2014 Jun;24(6):903-8. doi: 10.1007/s11695-014-1186-1.

PMID:
24566661
11.

Oct4 is required for lineage priming in the developing inner cell mass of the mouse blastocyst.

Le Bin GC, Muñoz-Descalzo S, Kurowski A, Leitch H, Lou X, Mansfield W, Etienne-Dumeau C, Grabole N, Mulas C, Niwa H, Hadjantonakis AK, Nichols J.

Development. 2014 Mar;141(5):1001-10. doi: 10.1242/dev.096875. Epub 2014 Feb 6.

12.

[Prospective study of gluco-lipidic hormone and peptide levels in morbidly obese patients after sleeve gastrectomy].

Bruna M, Gumbau V, Guaita M, Canelles E, Mulas C, Basés C, Celma I, Puche J, Marcaida G, Oviedo M, Vázquez A.

Cir Esp. 2014 Mar;92(3):175-81. doi: 10.1016/j.ciresp.2013.07.019. Epub 2013 Dec 27. Spanish.

PMID:
24378190
13.

Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients.

Solla P, Cannas A, Mulas CS, Perra S, Corona A, Bassareo PP, Marrosu F.

J Neurol. 2014 Feb;261(2):382-91. doi: 10.1007/s00415-013-7207-5. Epub 2013 Dec 28.

PMID:
24375016
14.

Rebuilding pluripotency from primordial germ cells.

Leitch HG, Nichols J, Humphreys P, Mulas C, Martello G, Lee C, Jones K, Surani MA, Smith A.

Stem Cell Reports. 2013 Jun 4;1(1):66-78. doi: 10.1016/j.stemcr.2013.03.004. eCollection 2013.

15.

A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life.

Macciò A, Madeddu C, Gramignano G, Mulas C, Floris C, Sanna E, Cau MC, Panzone F, Mantovani G.

Gynecol Oncol. 2012 Mar;124(3):417-25. doi: 10.1016/j.ygyno.2011.12.435. Epub 2011 Dec 20.

PMID:
22198049
16.

A lipoprotein source of cholesteryl esters is essential for proliferation of CEM-CCRF lymphoblastic cell line.

Uda S, Accossu S, Spolitu S, Collu M, Angius F, Sanna F, Banni S, Vacca C, Murru E, Mulas C, Diaz G, Batetta B.

Tumour Biol. 2012 Apr;33(2):443-53. doi: 10.1007/s13277-011-0270-6. Epub 2011 Dec 10.

PMID:
22161086
17.

[Massive intestinal ischaemia].

Mulas C, Gumbau V, Cantos M, Artigues E.

Cir Esp. 2012 Nov;90(9):e33. doi: 10.1016/j.ciresp.2011.06.013. Epub 2011 Oct 28. Spanish. No abstract available.

PMID:
22036175
18.

Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-beta for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled study.

Macciò A, Madeddu C, Gramignano G, Mulas C, Sanna E, Mantovani G.

Oncologist. 2010;15(8):894-902. doi: 10.1634/theoncologist.2010-0020. Epub 2010 Jul 20.

19.

Management of colonic volvulus. Experience in 75 patients.

Mulas C, Bruna M, García-Armengol J, Roig JV.

Rev Esp Enferm Dig. 2010 Apr;102(4):239-48. English, Spanish.

20.

Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications.

Macciò A, Madeddu C, Gramignano G, Mulas C, Floris C, Massa D, Astara G, Chessa P, Mantovani G.

J Mol Med (Berl). 2010 Jul;88(7):677-86. doi: 10.1007/s00109-010-0611-8. Epub 2010 Mar 26.

PMID:
20339829
21.

[Pain in right iliac fossa].

Marín AG, Gil JM, Mulas CC, Fuentes FT.

Cir Esp. 2011 May;89(5):321. doi: 10.1016/j.ciresp.2009.12.019. Epub 2010 Mar 20. Spanish. No abstract available.

PMID:
20304389
22.

Altered cholesterol ester cycle in skin fibroblasts from patients with Alzheimer's disease.

Pani A, Dessì S, Diaz G, La Colla P, Abete C, Mulas C, Angius F, Cannas MD, Orru CD, Cocco PL, Mandas A, Putzu P, Laurenzana A, Cellai C, Costanza AM, Bavazzano A, Mocali A, Paoletti F.

J Alzheimers Dis. 2009;18(4):829-41. doi: 10.3233/JAD-2009-1193.

PMID:
19749436
23.

Antiprion activity of cholesterol esterification modulators: a comparative study using ex vivo sheep fibroblasts and lymphocytes and mouse neuroblastoma cell lines.

Pani A, Norfo C, Abete C, Mulas C, Putzolu M, Laconi S, Orrù CD, Cannas MD, Vascellari S, La Colla P, Dessì S.

Antimicrob Agents Chemother. 2007 Nov;51(11):4141-7. Epub 2007 Aug 20.

24.

Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts.

Peiretti E, Dessì S, Mulas C, Abete C, Norfo C, Putzolu M, Fossarello M.

Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3450-8.

PMID:
17652712
25.

Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.

Gutiérrez-Juárez R, Pocai A, Mulas C, Ono H, Bhanot S, Monia BP, Rossetti L.

J Clin Invest. 2006 Jun;116(6):1686-95.

26.

Dietary restriction counteracts age-related changes in cholesterol metabolism in the rat.

Mulas MF, Demuro G, Mulas C, Putzolu M, Cavallini G, Donati A, Bergamini E, Dessi S.

Mech Ageing Dev. 2005 Jun-Jul;126(6-7):648-54. Epub 2005 Jan 8.

PMID:
15888318
27.

Feasibility of high-dose interferon-alpha2b adjuvant therapy for high-risk resected cutaneous melanoma.

Muggiano A, Mulas C, Fiori B, Liciardi G, Pintus M, Tanca L, Tedde A, Turno R, Desogus A.

Melanoma Res. 2004 Apr;14(2):S1-7.

PMID:
15057049
28.

Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy.

Mantovani G, Macciò A, Madeddu C, Mulas C, Massa E, Astara G, Ferreli L, Mudu MC, Gramignano G, Murgia V, Lusso MR, Mocci M, Cardia A, Mura L.

Oncol Rep. 2002 Jul-Aug;9(4):887-96.

PMID:
12066227
29.

Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer.

Mantovani G, Macciò A, Mulas C, Massa E, Madeddu C, Mura L, Contu P, Versace R.

Oncol Rep. 2002 May-Jun;9(3):661-70.

PMID:
11956647
30.

Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status.

Mantovani G, Macciò A, Madeddu C, Mura L, Gramignano G, Lusso MR, Mulas C, Mudu MC, Murgia V, Camboni P, Massa E, Ferreli L, Contu P, Rinaldi A, Sanjust E, Atzei D, Elsener B.

Int J Cancer. 2002 Mar 1;98(1):84-91.

31.

Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity.

Mantovani G, Proto E, Massa E, Mulas C, Madeddu C, Mura L, Mudu MC, Astara G, Murgia V, Gramignano G, Ferreli L, Camboni P, Lusso MR, Mocci M, Tore G, Mura M, Amichetti M, Maccio A.

Int J Oncol. 2002 Feb;20(2):419-27.

PMID:
11788911
32.

Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites.

Mantovani G, Macciò A, Madeddu C, Mura L, Massa E, Mudu MC, Mulas C, Lusso MR, Gramignano G, Piras MB.

J Mol Med (Berl). 2001 Jul;79(7):406-14.

PMID:
11466563
33.

Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites.

Mantovani G, Macciò A, Mura L, Massa E, Mudu MC, Mulas C, Lusso MR, Madeddu C, Dessì A.

J Mol Med (Berl). 2000;78(10):554-61.

PMID:
11199328
34.

Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy.

Mantovani G, Maccio A, Madeddu C, Massa E, Mudu MC, Mulas C, Gramignano G, Massidda S, Murgia V, Lusso MR, Mura L.

Int J Oncol. 2001 Feb;18(2):383-91.

PMID:
11172608
35.

Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical outcome, toxicity and organ/function preservation.

Mantovani G, Maccio A, Massa E, Mulas C, Mudu MC, Massidda S, Massa D, Murgia V, Ferreli L, Succu G, Astara G, Proto E, Tore G, Mura M, Maxia G.

Int J Oncol. 2000 Jun;16(6):1227-33.

PMID:
10812000
36.
38.

Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical response and organ/function preservation.

Mantovani G, Macciò A, Massa E, Mulas C, Mudu MC, Massidda S, Massa D, Murgia V, Ferreli L, Succu G, Astara G, Proto E, Tore G, Mura M, Maxia G.

Oncol Rep. 1999 Nov-Dec;6(6):1425-30.

PMID:
10523724
39.

Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2.

Mantovani G, Gebbia V, Airoldi M, Bumma C, Contu P, Bianchi A, Ghiani M, Dessì D, Massa E, Curreli L, Lampis B, Lai P, Mulas C, Testa A, Proto E, Cadeddu G, Tore G.

Cancer Immunol Immunother. 1998 Nov;47(3):149-56.

PMID:
9829840
40.

Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.

Mantovani G, Ghiani M, Lai P, Maccio A, Dessi D, Succu G, Massa D, Curreli L, Mulas C, Esu S, Proto E, Cadeddu G, Tore G.

Oncol Rep. 1998 Nov-Dec;5(6):1499-505.

PMID:
9769395
41.

[Can malnutrition be prevented in patients on chronic extracorporeal dialysis?].

Mazzotta A, Calabrese G, Mulas C, Pisano M, Vagelli G, Gonella M.

Minerva Urol Nefrol. 1994 Dec;46(4):227-31. Italian.

PMID:
7701410

Supplemental Content

Support Center